The Cooper Companies, Inc. (COO): Price and Financial Metrics
The Cooper Companies, Inc. (COO)
Today's Latest Price: $334.61 USD
Updated Dec 2 7:00pm
Add COO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
COO Stock Summary
- COO has a market capitalization of $17,817,827,550 -- more than approximately 89.06% of US stocks.
- Cooper Companies Inc's stock had its IPO on January 1, 1986, making it an older stock than 92.95% of US equities in our set.
- In terms of volatility of its share price, COO is more volatile than just 8.3% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to Cooper Companies Inc are XYL, STE, TFX, CBRE, and FTV.
- COO's SEC filings can be seen here. And to visit Cooper Companies Inc's official web site, go to www.coopercos.com.
COO Stock Price Chart Interactive Chart >
COO Price/Volume Stats
| Current price | $334.61 | 52-week high | $371.59 |
| Prev. close | $334.04 | 52-week low | $236.68 |
| Day low | $331.12 | Volume | 206,604 |
| Day high | $335.79 | Avg. volume | 322,148 |
| 50-day MA | $339.67 | Dividend yield | 0.02% |
| 200-day MA | $310.35 | Market Cap | 17.85B |
The Cooper Companies, Inc. (COO) Company Bio
The Cooper Companies operates through two business units. CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women. The company was founded in 1980 and is based in Pleasanton, California.
COO Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $334.61 | $24.85 | -93% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Cooper Companies Inc. To summarize, we found that Cooper Companies Inc ranked in the 9th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Cooper Companies Inc, consider:
- The company's debt burden, as measured by earnings divided by interest payments, is 7.73; that's higher than 64.81% of US stocks in the Healthcare sector that have positive free cash flow.
- Its compound free cash flow growth rate, as measured over the past 5.5 years, is -0.04% -- higher than only 19.84% of stocks in our DCF forecasting set.
- COO's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 32.62% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -93% |
| 1% | -93% |
| 2% | -93% |
| 3% | -92% |
| 4% | -92% |
| 5% | -92% |
EW, SXTC, TEVA, BHC, and LUMO can be thought of as valuation peers to COO, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...